

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.05528182 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.78253803 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.42484246 |
| 4 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.75820848 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.72798902 |
| 6 | drug catabolic process (GO:0042737) | 6.60977448 |
| 7 | cellular glucuronidation (GO:0052695) | 6.48594933 |
| 8 | lipoprotein transport (GO:0042953) | 6.41040985 |
| 9 | regulation of bile acid biosynthetic process (GO:0070857) | 6.40940554 |
| 10 | drug metabolic process (GO:0017144) | 6.38199650 |
| 11 | glucuronate metabolic process (GO:0019585) | 6.29727412 |
| 12 | uronic acid metabolic process (GO:0006063) | 6.29727412 |
| 13 | urea metabolic process (GO:0019627) | 6.20630305 |
| 14 | NADH metabolic process (GO:0006734) | 6.16819228 |
| 15 | intestinal absorption (GO:0050892) | 5.99119873 |
| 16 | urea cycle (GO:0000050) | 5.89751901 |
| 17 | hormone catabolic process (GO:0042447) | 5.86231549 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 5.71266520 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 5.68443744 |
| 20 | omega-hydroxylase P450 pathway (GO:0097267) | 5.57910873 |
| 21 | bile acid and bile salt transport (GO:0015721) | 5.57317366 |
| 22 | regulation of guanylate cyclase activity (GO:0031282) | 5.53018336 |
| 23 | fructose metabolic process (GO:0006000) | 5.37500274 |
| 24 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.92343154 |
| 25 | ethanol oxidation (GO:0006069) | 4.87482490 |
| 26 | bile acid metabolic process (GO:0008206) | 4.85528796 |
| 27 | alkaloid metabolic process (GO:0009820) | 4.76065052 |
| 28 | flavonoid metabolic process (GO:0009812) | 4.71145599 |
| 29 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.41811528 |
| 30 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.41811528 |
| 31 | endocrine process (GO:0050886) | 4.41811528 |
| 32 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.29041811 |
| 33 | arginine metabolic process (GO:0006525) | 4.28789739 |
| 34 | phospholipid efflux (GO:0033700) | 4.27442060 |
| 35 | plasma lipoprotein particle assembly (GO:0034377) | 4.18894045 |
| 36 | diacylglycerol metabolic process (GO:0046339) | 4.18451056 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.12324131 |
| 38 | virion attachment to host cell (GO:0019062) | 4.06298430 |
| 39 | adhesion of symbiont to host cell (GO:0044650) | 4.06298430 |
| 40 | phenylpropanoid metabolic process (GO:0009698) | 3.97748037 |
| 41 | lipoprotein metabolic process (GO:0042157) | 3.97257700 |
| 42 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93565349 |
| 43 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93565349 |
| 44 | renal system process involved in regulation of blood volume (GO:0001977) | 3.93335456 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 3.93181551 |
| 46 | regulation of systemic arterial blood pressure (GO:0003073) | 3.91140469 |
| 47 | ethanol metabolic process (GO:0006067) | 3.83840443 |
| 48 | protein-lipid complex assembly (GO:0065005) | 3.79082855 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77753900 |
| 50 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.75786286 |
| 51 | drug transmembrane transport (GO:0006855) | 3.74087525 |
| 52 | midgut development (GO:0007494) | 3.73095434 |
| 53 | regulation of cellular extravasation (GO:0002691) | 3.72871893 |
| 54 | vitamin biosynthetic process (GO:0009110) | 3.72807665 |
| 55 | drug transport (GO:0015893) | 3.70630426 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.66953644 |
| 57 | peptide hormone processing (GO:0016486) | 3.64501315 |
| 58 | heme transport (GO:0015886) | 3.63978755 |
| 59 | positive regulation of lipid catabolic process (GO:0050996) | 3.61785891 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 3.60942342 |
| 61 | macromolecular complex remodeling (GO:0034367) | 3.60942342 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.60942342 |
| 63 | fat-soluble vitamin metabolic process (GO:0006775) | 3.60008721 |
| 64 | adhesion of symbiont to host (GO:0044406) | 3.57694316 |
| 65 | oxidative demethylation (GO:0070989) | 3.57626559 |
| 66 | vitamin transport (GO:0051180) | 3.52088904 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.50894162 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 3.50894162 |
| 69 | glyoxylate metabolic process (GO:0046487) | 3.50413340 |
| 70 | cholesterol efflux (GO:0033344) | 3.46390401 |
| 71 | digestion (GO:0007586) | 3.46237636 |
| 72 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.43349290 |
| 73 | cholesterol homeostasis (GO:0042632) | 3.40831311 |
| 74 | homocysteine metabolic process (GO:0050667) | 3.40076857 |
| 75 | sterol homeostasis (GO:0055092) | 3.34906515 |
| 76 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.34876965 |
| 77 | regulation of cGMP biosynthetic process (GO:0030826) | 3.34093856 |
| 78 | urate metabolic process (GO:0046415) | 3.32161466 |
| 79 | vitamin A metabolic process (GO:0006776) | 3.28678366 |
| 80 | peptide catabolic process (GO:0043171) | 3.28513336 |
| 81 | vitamin D metabolic process (GO:0042359) | 3.26512939 |
| 82 | drinking behavior (GO:0042756) | 3.24997143 |
| 83 | complement activation, alternative pathway (GO:0006957) | 3.24157110 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 3.22410671 |
| 85 | citrulline biosynthetic process (GO:0019240) | 3.21523033 |
| 86 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.21497203 |
| 87 | reverse cholesterol transport (GO:0043691) | 3.19214049 |
| 88 | L-ascorbic acid metabolic process (GO:0019852) | 3.16209904 |
| 89 | regulation of protein activation cascade (GO:2000257) | 3.13241628 |
| 90 | proline metabolic process (GO:0006560) | 3.13058178 |
| 91 | bile acid biosynthetic process (GO:0006699) | 3.13021357 |
| 92 | vitamin transmembrane transport (GO:0035461) | 3.12673985 |
| 93 | xenobiotic metabolic process (GO:0006805) | 3.12461406 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.12125596 |
| 95 | regulation of vitamin metabolic process (GO:0030656) | 3.09461676 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.08270182 |
| 97 | protein-lipid complex subunit organization (GO:0071825) | 3.06542954 |
| 98 | antibacterial humoral response (GO:0019731) | 3.05938871 |
| 99 | oxaloacetate metabolic process (GO:0006107) | 3.05771341 |
| 100 | regulation of fibrinolysis (GO:0051917) | 3.05428607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.93220941 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.42012206 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.36059337 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.23982045 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.82743767 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.82454424 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.61208486 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.38946258 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.33882344 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98093532 |
| 11 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.65674098 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.59796587 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.33795930 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.28037745 |
| 15 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.17692012 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.06669354 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02247568 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01598795 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.98255541 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97931105 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.97256442 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.93108183 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81524277 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.79267998 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72705876 |
| 26 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.68838582 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.66786255 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63183407 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59290106 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49904074 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45840788 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45389445 |
| 33 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.44776353 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42307820 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35227109 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.30165434 |
| 37 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.25260548 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24983968 |
| 39 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23205465 |
| 40 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23104938 |
| 41 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18015584 |
| 42 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.16019982 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14754474 |
| 44 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12419262 |
| 45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.06189812 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.03573800 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02765540 |
| 48 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01212319 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00449165 |
| 50 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99829366 |
| 51 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97969287 |
| 52 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.95684097 |
| 53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94184167 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93122853 |
| 55 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91220706 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91029508 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90490123 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89532277 |
| 59 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89364917 |
| 60 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88772206 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88524265 |
| 62 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86903070 |
| 63 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.86218812 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85976716 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84653352 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81665626 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81582690 |
| 68 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80866219 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.80474374 |
| 70 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80356451 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80028533 |
| 72 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79797072 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.79741587 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79722128 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79615480 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79474184 |
| 77 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79272923 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.78790048 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78775858 |
| 80 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78512377 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77526040 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.77524763 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77206889 |
| 84 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77140052 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76176824 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75869727 |
| 87 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.75661094 |
| 88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75195591 |
| 89 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.74919778 |
| 90 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74911222 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74527326 |
| 92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74269010 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74049803 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.72535156 |
| 95 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.72145831 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71005654 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.70356837 |
| 98 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.69490091 |
| 99 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69251872 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69065507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.33814216 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.25578578 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.81940423 |
| 4 | MP0001666_abnormal_nutrient_absorption | 4.88645125 |
| 5 | MP0005365_abnormal_bile_salt | 4.87118622 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.53863122 |
| 7 | MP0004019_abnormal_vitamin_homeostasis | 3.44628867 |
| 8 | MP0009840_abnormal_foam_cell | 3.37830166 |
| 9 | MP0004147_increased_porphyrin_level | 2.73329816 |
| 10 | MP0003252_abnormal_bile_duct | 2.69727009 |
| 11 | MP0003868_abnormal_feces_composition | 2.60099182 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.57900053 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.50947865 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.44533457 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.38961128 |
| 16 | MP0005332_abnormal_amino_acid | 2.35531082 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.09558091 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.07152639 |
| 19 | MP0009643_abnormal_urine_homeostasis | 1.86361397 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 1.84943755 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.82845114 |
| 22 | MP0001764_abnormal_homeostasis | 1.80161926 |
| 23 | MP0005409_darkened_coat_color | 1.66374281 |
| 24 | MP0003195_calcinosis | 1.65114195 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.58841269 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.48670760 |
| 27 | MP0005670_abnormal_white_adipose | 1.43909593 |
| 28 | MP0003866_abnormal_defecation | 1.38717260 |
| 29 | MP0000609_abnormal_liver_physiology | 1.38409292 |
| 30 | MP0001664_abnormal_digestion | 1.37820968 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.34672429 |
| 32 | MP0009697_abnormal_copulation | 1.27853813 |
| 33 | MP0005166_decreased_susceptibility_to | 1.23223940 |
| 34 | MP0000538_abnormal_urinary_bladder | 1.18113055 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.16346160 |
| 36 | MP0003718_maternal_effect | 1.15336525 |
| 37 | MP0000490_abnormal_crypts_of | 1.12863012 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12145645 |
| 39 | MP0004043_abnormal_pH_regulation | 1.12037370 |
| 40 | MP0003879_abnormal_hair_cell | 1.11910993 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.11757910 |
| 42 | MP0002136_abnormal_kidney_physiology | 1.11415517 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.06822323 |
| 44 | MP0005535_abnormal_body_temperature | 1.03009758 |
| 45 | MP0000477_abnormal_intestine_morphology | 1.00534908 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 0.99739774 |
| 47 | MP0000678_abnormal_parathyroid_gland | 0.98775973 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 0.96101824 |
| 49 | MP0002971_abnormal_brown_adipose | 0.93633873 |
| 50 | MP0005451_abnormal_body_composition | 0.93384489 |
| 51 | MP0005448_abnormal_energy_balance | 0.91640692 |
| 52 | MP0001756_abnormal_urination | 0.90744001 |
| 53 | MP0002822_catalepsy | 0.85030310 |
| 54 | MP0008469_abnormal_protein_level | 0.82597921 |
| 55 | MP0009642_abnormal_blood_homeostasis | 0.82012475 |
| 56 | MP0001501_abnormal_sleep_pattern | 0.80387974 |
| 57 | MP0001663_abnormal_digestive_system | 0.80350335 |
| 58 | MP0001188_hyperpigmentation | 0.78629370 |
| 59 | MP0004858_abnormal_nervous_system | 0.76797572 |
| 60 | MP0000462_abnormal_digestive_system | 0.75293354 |
| 61 | MP0001873_stomach_inflammation | 0.73597482 |
| 62 | MP0001845_abnormal_inflammatory_respons | 0.73426406 |
| 63 | MP0000604_amyloidosis | 0.68471526 |
| 64 | MP0009764_decreased_sensitivity_to | 0.67103679 |
| 65 | MP0009785_altered_susceptibility_to | 0.66498356 |
| 66 | MP0009115_abnormal_fat_cell | 0.66170708 |
| 67 | MP0004270_analgesia | 0.66066641 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 0.65751174 |
| 69 | MP0008872_abnormal_physiological_respon | 0.65493495 |
| 70 | MP0000230_abnormal_systemic_arterial | 0.59499176 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.58388571 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.57544415 |
| 73 | MP0000598_abnormal_liver_morphology | 0.57121219 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.56197651 |
| 75 | MP0000249_abnormal_blood_vessel | 0.54714064 |
| 76 | MP0005334_abnormal_fat_pad | 0.54260559 |
| 77 | MP0005395_other_phenotype | 0.53828688 |
| 78 | MP0003638_abnormal_response/metabolism_ | 0.52392809 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.51060528 |
| 80 | MP0002796_impaired_skin_barrier | 0.47709293 |
| 81 | MP0003953_abnormal_hormone_level | 0.47199093 |
| 82 | MP0002098_abnormal_vibrissa_morphology | 0.47124822 |
| 83 | MP0009763_increased_sensitivity_to | 0.44965119 |
| 84 | MP0001881_abnormal_mammary_gland | 0.44129999 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.43561637 |
| 86 | MP0003329_amyloid_beta_deposits | 0.43347166 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.42615595 |
| 88 | MP0005025_abnormal_response_to | 0.41757879 |
| 89 | MP0002166_altered_tumor_susceptibility | 0.40707412 |
| 90 | MP0005408_hypopigmentation | 0.38622260 |
| 91 | MP0006082_CNS_inflammation | 0.38103319 |
| 92 | MP0003436_decreased_susceptibility_to | 0.36266409 |
| 93 | MP0005501_abnormal_skin_physiology | 0.35685079 |
| 94 | MP0006138_congestive_heart_failure | 0.35483906 |
| 95 | MP0001485_abnormal_pinna_reflex | 0.35198972 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.35043560 |
| 97 | MP0000465_gastrointestinal_hemorrhage | 0.34223939 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.33326598 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.30865892 |
| 100 | MP0003724_increased_susceptibility_to | 0.30673402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 9.73968852 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 7.66674960 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 6.29453164 |
| 4 | Hydroxyprolinuria (HP:0003080) | 6.29453164 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.02469582 |
| 6 | Malnutrition (HP:0004395) | 5.89266263 |
| 7 | Fat malabsorption (HP:0002630) | 5.10716065 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.98078329 |
| 9 | Complement deficiency (HP:0004431) | 4.40599465 |
| 10 | Acanthocytosis (HP:0001927) | 4.40585180 |
| 11 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.31498310 |
| 12 | Hyperglycinuria (HP:0003108) | 4.17400254 |
| 13 | Chronic diarrhea (HP:0002028) | 4.14200848 |
| 14 | Xanthomatosis (HP:0000991) | 4.11612754 |
| 15 | Abnormality of vitamin B metabolism (HP:0004340) | 4.05134675 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.97561446 |
| 17 | Abnormality of vitamin metabolism (HP:0100508) | 3.95886758 |
| 18 | Widely patent fontanelles and sutures (HP:0004492) | 3.94244485 |
| 19 | Abnormality of complement system (HP:0005339) | 3.85764113 |
| 20 | Ileus (HP:0002595) | 3.85682115 |
| 21 | Abnormality of urine glucose concentration (HP:0011016) | 3.85568280 |
| 22 | Glycosuria (HP:0003076) | 3.85568280 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77400506 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.77400506 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72484251 |
| 26 | Confusion (HP:0001289) | 3.68190599 |
| 27 | Steatorrhea (HP:0002570) | 3.47640323 |
| 28 | Proximal tubulopathy (HP:0000114) | 3.46497614 |
| 29 | Deep venous thrombosis (HP:0002625) | 3.38789382 |
| 30 | Pigmentary retinal degeneration (HP:0001146) | 3.38786919 |
| 31 | Alkalosis (HP:0001948) | 3.35865926 |
| 32 | Hyperammonemia (HP:0001987) | 3.35162540 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.23890073 |
| 34 | Nausea (HP:0002018) | 3.21180274 |
| 35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.19526697 |
| 36 | Nephrolithiasis (HP:0000787) | 3.12374281 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.11970168 |
| 38 | Intrahepatic cholestasis (HP:0001406) | 3.09467793 |
| 39 | Glomerulonephritis (HP:0000099) | 3.09410495 |
| 40 | Metabolic alkalosis (HP:0200114) | 3.04414360 |
| 41 | Hyperactive renin-angiotensin system (HP:0000841) | 3.01857915 |
| 42 | Hyperphosphaturia (HP:0003109) | 2.99638284 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97735260 |
| 44 | Prolonged partial thromboplastin time (HP:0003645) | 2.94512753 |
| 45 | Abnormal urine phosphate concentration (HP:0012599) | 2.93562088 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 2.91210927 |
| 47 | Hypophosphatemia (HP:0002148) | 2.90879607 |
| 48 | Facial shape deformation (HP:0011334) | 2.90525505 |
| 49 | Potter facies (HP:0002009) | 2.90525505 |
| 50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.90477090 |
| 51 | Thin bony cortex (HP:0002753) | 2.85682845 |
| 52 | Wide cranial sutures (HP:0010537) | 2.83772663 |
| 53 | Hyperuricemia (HP:0002149) | 2.83231945 |
| 54 | Increased purine levels (HP:0004368) | 2.83231945 |
| 55 | Abdominal distention (HP:0003270) | 2.73345555 |
| 56 | Megaloblastic anemia (HP:0001889) | 2.69165155 |
| 57 | Epidermoid cyst (HP:0200040) | 2.68992763 |
| 58 | Hyperlipoproteinemia (HP:0010980) | 2.64063382 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.64042002 |
| 60 | Hemorrhage of the eye (HP:0011885) | 2.62583633 |
| 61 | Metabolic acidosis (HP:0001942) | 2.59597371 |
| 62 | Nephritis (HP:0000123) | 2.57133601 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.54548775 |
| 64 | Gout (HP:0001997) | 2.50758374 |
| 65 | Rickets (HP:0002748) | 2.41736834 |
| 66 | Poikilocytosis (HP:0004447) | 2.41332280 |
| 67 | Focal segmental glomerulosclerosis (HP:0000097) | 2.35403177 |
| 68 | Decreased circulating renin level (HP:0003351) | 2.34478436 |
| 69 | Irritability (HP:0000737) | 2.28769784 |
| 70 | Congenital sensorineural hearing impairment (HP:0008527) | 2.26349449 |
| 71 | Abnormality of renin-angiotensin system (HP:0000847) | 2.22563034 |
| 72 | Hypotension (HP:0002615) | 2.20839315 |
| 73 | Enlarged epiphyses (HP:0010580) | 2.14935876 |
| 74 | Delayed epiphyseal ossification (HP:0002663) | 2.14634625 |
| 75 | Cerebral palsy (HP:0100021) | 2.12570419 |
| 76 | Osteomalacia (HP:0002749) | 2.11890070 |
| 77 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.07815605 |
| 78 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04801414 |
| 79 | Pancreatitis (HP:0001733) | 2.04392463 |
| 80 | Posterior subcapsular cataract (HP:0007787) | 2.02349598 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 1.98581752 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98581752 |
| 83 | Vascular calcification (HP:0004934) | 1.97158492 |
| 84 | Delayed CNS myelination (HP:0002188) | 1.94795351 |
| 85 | Protuberant abdomen (HP:0001538) | 1.94307888 |
| 86 | Elevated alkaline phosphatase (HP:0003155) | 1.93926143 |
| 87 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92687560 |
| 88 | Eczematoid dermatitis (HP:0000976) | 1.92185591 |
| 89 | Joint hemorrhage (HP:0005261) | 1.91273063 |
| 90 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90441545 |
| 91 | Villous atrophy (HP:0011473) | 1.90441545 |
| 92 | Renal tubular acidosis (HP:0001947) | 1.87742278 |
| 93 | Lethargy (HP:0001254) | 1.87370390 |
| 94 | Hyperparathyroidism (HP:0000843) | 1.86446326 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 1.86196614 |
| 96 | Hyperbilirubinemia (HP:0002904) | 1.85095119 |
| 97 | Renal tubular dysfunction (HP:0000124) | 1.82268152 |
| 98 | Abnormal glucose tolerance (HP:0001952) | 1.82262849 |
| 99 | Abnormality of serum amino acid levels (HP:0003112) | 1.82039813 |
| 100 | Glomerulosclerosis (HP:0000096) | 1.81960935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 8.38655951 |
| 2 | ERN1 | 4.64760891 |
| 3 | MST1R | 4.13885459 |
| 4 | RIPK1 | 3.62919122 |
| 5 | PRKG2 | 3.28954479 |
| 6 | MAP3K10 | 2.87362250 |
| 7 | OXSR1 | 2.61235574 |
| 8 | STK39 | 2.41267131 |
| 9 | EPHA2 | 2.22220317 |
| 10 | FGFR4 | 2.17568445 |
| 11 | MAP3K2 | 1.91783240 |
| 12 | TYK2 | 1.83572673 |
| 13 | PDK2 | 1.74763694 |
| 14 | EPHA3 | 1.69573751 |
| 15 | MAP3K12 | 1.68937097 |
| 16 | TESK2 | 1.65532589 |
| 17 | MET | 1.58263835 |
| 18 | PTK6 | 1.54096715 |
| 19 | PRPF4B | 1.37441589 |
| 20 | TNIK | 1.27960004 |
| 21 | PIK3CA | 1.26285990 |
| 22 | FGFR3 | 1.25553024 |
| 23 | GRK6 | 1.21264158 |
| 24 | EPHB1 | 1.20809796 |
| 25 | AKT3 | 1.20536711 |
| 26 | EPHB2 | 1.16346983 |
| 27 | EPHA4 | 1.15973697 |
| 28 | DDR2 | 1.14070354 |
| 29 | MAP3K1 | 1.12944066 |
| 30 | STK24 | 1.11048448 |
| 31 | MYLK | 1.10179958 |
| 32 | MST4 | 1.09579775 |
| 33 | NLK | 1.02826518 |
| 34 | PRKACG | 1.02673883 |
| 35 | MAP4K1 | 0.98426376 |
| 36 | MATK | 0.97432760 |
| 37 | PRKAA2 | 0.96617839 |
| 38 | PDPK1 | 0.96303597 |
| 39 | MAP2K2 | 0.96182468 |
| 40 | MAPK11 | 0.94847050 |
| 41 | ERBB2 | 0.88344626 |
| 42 | MAP3K3 | 0.84206060 |
| 43 | LMTK2 | 0.82303293 |
| 44 | PIK3CG | 0.81542405 |
| 45 | PIM1 | 0.76739328 |
| 46 | MAP2K6 | 0.75602186 |
| 47 | CASK | 0.70912194 |
| 48 | PRKCZ | 0.70319580 |
| 49 | RIPK4 | 0.70258972 |
| 50 | PDK1 | 0.70107175 |
| 51 | FER | 0.69654390 |
| 52 | DYRK1B | 0.68946045 |
| 53 | PRKCA | 0.65091441 |
| 54 | MAP3K11 | 0.64212722 |
| 55 | CDC42BPA | 0.64131438 |
| 56 | ABL2 | 0.61546315 |
| 57 | JAK1 | 0.60478406 |
| 58 | KSR2 | 0.60152670 |
| 59 | TESK1 | 0.59941244 |
| 60 | BMPR2 | 0.59287439 |
| 61 | TBK1 | 0.58793295 |
| 62 | WNK3 | 0.56144415 |
| 63 | IRAK1 | 0.54809521 |
| 64 | RET | 0.54184215 |
| 65 | JAK2 | 0.51598097 |
| 66 | TAOK1 | 0.48330128 |
| 67 | SRC | 0.47533235 |
| 68 | CDK6 | 0.46581564 |
| 69 | CSF1R | 0.46563716 |
| 70 | PTK2 | 0.40880807 |
| 71 | PRKCD | 0.40864897 |
| 72 | YES1 | 0.39422940 |
| 73 | IGF1R | 0.37598429 |
| 74 | FYN | 0.37591869 |
| 75 | CAMK2G | 0.35481334 |
| 76 | CAMK2D | 0.34161742 |
| 77 | PDGFRA | 0.33477678 |
| 78 | PRKACA | 0.31804452 |
| 79 | IKBKE | 0.31422885 |
| 80 | TRIB3 | 0.30004515 |
| 81 | NEK6 | 0.27407714 |
| 82 | ITK | 0.27230477 |
| 83 | ZAP70 | 0.25667717 |
| 84 | GRK1 | 0.24865994 |
| 85 | PAK4 | 0.24844449 |
| 86 | FRK | 0.24228981 |
| 87 | DAPK2 | 0.23414759 |
| 88 | MAP3K14 | 0.22592562 |
| 89 | CAMK2B | 0.22492049 |
| 90 | BMX | 0.22426991 |
| 91 | SYK | 0.22348369 |
| 92 | TEC | 0.22241531 |
| 93 | BTK | 0.21549687 |
| 94 | MELK | 0.20891518 |
| 95 | CSK | 0.20204763 |
| 96 | PRKG1 | 0.19947405 |
| 97 | PRKCB | 0.19570024 |
| 98 | NEK9 | 0.18824117 |
| 99 | CDK19 | 0.18304907 |
| 100 | JAK3 | 0.17737801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.96571281 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.52171075 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.51199974 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41997808 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.02839152 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.95925784 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.92897326 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.92770180 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.74610827 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74118358 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.65616969 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.59541635 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.50429970 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.28165531 |
| 15 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.23005735 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.17093800 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 2.02983560 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00506140 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.95212014 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87544329 |
| 21 | * Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.85957239 |
| 22 | Mineral absorption_Homo sapiens_hsa04978 | 1.84811746 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.82549855 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.81316712 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.80917354 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72326845 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65583288 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.55917671 |
| 29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.51071536 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.49222345 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.45445813 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.41049930 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.39938474 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37247506 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32917638 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31397090 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30438953 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29477584 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15712363 |
| 40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12943602 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12886280 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02489064 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01994138 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01053054 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.96381711 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92495605 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.86393804 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84875140 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80029146 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77205848 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76015820 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71263595 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63076658 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59776172 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58812130 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57710587 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55458670 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53686620 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53085981 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.53018239 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52311718 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48133413 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.47648738 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46525321 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44866991 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43572052 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41084793 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39780153 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37473687 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35801341 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35667919 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33236179 |
| 73 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.33163714 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31860034 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31518789 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.30924907 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29028469 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.27777474 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24099904 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23955141 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22958500 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20640982 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.17471726 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17252131 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16861661 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16370594 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.15307364 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.13875685 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.09747359 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.06515228 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.06327333 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06195150 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06040803 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.01374395 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.00917053 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | -0.0406124 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0357245 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0334920 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.0308016 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0065115 |

